Trial
NCT04524949
IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Imcyse SA
Collaborators
—
Condition
Diabetes Mellitus, Type 1
Intervention
IMCY-0098 450 μg
Why stopped
No efficacy at primary analysis after 1 year. Long term follow-up stopped
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-24